Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Glioma 1Glioblastoma 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Polymerase Chain Reaction 5Watchful Waiting 2Taxes 2Paclitaxel 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2nirogacestat 1fludarabine 1emvododstat 1carmustine, poliferprosan 20 drug combination 1axicabtagene ciloleucel 1Vorinostat 1Vincristine 1Vinblastine 1Sodium Chloride 1Smoking Devices 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Procarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × HIV Infections × carmustine, poliferprosan 20 drug combination × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡